Imperial College's London's vaccine candidate moves on to next phase

Eren Sengezer FXStreet

After receiving successful results during the initial phase with 15 volunteers, Imperial College London's COVID-19 vaccine candidate is ready for the next phase, Imperial College London announced in a press release.

"In this next phase of the trial, 105 participants aged 18-75 will be randomised to receive their first shot of one of three doses of the vaccine at a west London facility, followed by a booster four weeks later," the statement read. "The three arms of the study are blinded, so neither participant nor clinical staff will know which dose they have received."

Market reaction

This headline doesn't seem to be having a significant impact on market sentiment. As of writing, the UK's FTSE 100 Index was up 0.52% on the day at 6,282.

Author

Eren Sengezer

FXStreet

As an economist at heart, Eren Sengezer specializes in the assessment of the short-term and long-term impacts of macroeconomic data, central bank policies and political developments on financial assets.

GBP/USD: Gains remains capped below 1.3400

GBP/USD trades in positive territory, with the upside capped below 1.3400 in the European session on Friday. The US Dollar extends weakness following a weaker-than-expected US Nonfarm Payrolls report, which fades Fed rate hike expectations.

EUR/USD stays firm around 1.1450 amid weaker US Dollar

EUR/USD remains on the front foot at around 1.1450 in European trading on Friday. The pair seems poised to register gains for the first time in three weeks as receding US Federal Reserve rate hike bets keep the US Dollar under pressure.

Gold stays on track to snap four-week losing streak amid fading Fed hike bets, weak USD

Gold retains its bullish bias for the third straight day and traders near a one-and-a-half-week high during the first half of the European session. The precious metal seems poised to register gains for the first time in five weeks, with bulls still awaiting a move beyond the $4,200 mark before positioning for an extension of this week's recovery from the lowest level since November 2025.

Hyperliquid gears up for a higher leg as bullish momentum resurfaces

Hyperliquid (HYPE) extends gains above $66 maintaining a long-term upward trend supported by its rising 50-day EMA around $60. Retail demand for HYPE rises in the near term, with Open Interest up around 5% over 24 hours as funding rates hold above zero, while institutional demand remains muted so far this week.

Economics week ahead

Market attention turns to next week's FOMC minutes for any signs of what could shift a divided Committee from a hold toward rate hikes. The dot plot from the last meeting made clear that policymakers are split on whether rate hikes are warranted, but with forward guidance getting tamped down under Chair Warsh, the Fed's reaction function remains uncertain in terms of what exactly would build broader support for more restrictive policy.

Kevin Warsh offers no policy clues: Why markets still got their answer

Financial markets came to Sintra looking for clues about the Federal Reserve's (Fed) next move. They largely left with confirmation that Fed Chair Kevin Warsh intends to make those clues much harder to find.